OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RNA modification m 6 Am: the role in cardiac biology
Daniel Benák, František Kolář, Lu Zhang, et al.
Epigenetics (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 17

Showing 17 citing articles:

Epitranscriptomic regulation in fasting hearts: implications for cardiac health
Daniel Benák, Kristýna Holzerová, Jaroslav Hrdlička, et al.
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-14
Open Access | Times Cited: 7

The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitus
Daniel Benák, Stepanka Benakova, Lydie Plecitá‐Hlavatá, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15

Molecular and Cellular Mechanisms Underlying the Cardiac Hypertrophic and Pro-Remodelling Effects of Leptin
Morris Karmazyn, Xiaohong Tracey Gan
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1137-1137
Open Access | Times Cited: 5

METTL Family in Healthy and Disease
Jiejie He, Fengchen Hao, Shiqi Song, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4

Epitranscriptomics in atherosclerosis: Unraveling RNA modifications, editing and splicing and their implications in vascular disease
Victoria Stopa, Dimitra Dafou, Korina Karagianni, et al.
Vascular Pharmacology (2025) Vol. 159, pp. 107496-107496
Closed Access

FTO in health and disease
Daniel Benák, Anna Ševčíková, Kristýna Holzerová, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3

The Role of Selected Epigenetic Pathways in Cardiovascular Diseases as a Potential Therapeutic Target
Anna Wołowiec, Łukasz Wołowiec, Grzegorz Grześk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13723-13723
Open Access | Times Cited: 7

Epitranscriptomic regulations in the heart
D Benak, František Kolář, Markéta Hlaváčková
Physiological Research (2024)
Open Access | Times Cited: 2

Unravelling the impact of RNA methylation genetic and epigenetic machinery in the treatment of cardiomyopathy
Li Liu, Linxing Yu, Y Wang, et al.
Pharmacological Research (2024) Vol. 207, pp. 107305-107305
Open Access | Times Cited: 2

Unveiling the proteome of the fasting heart: Insights into HIF-1 pathway regulation
Daniel Benák, Kristýna Holzerová, František Kolář, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 2

Sixty Years of Heart Research in the Institute of Physiology of the Czech Academy of Sciences
B Ošťádal, František Kolář
Physiological Research (2024), Iss. Suppl 1, pp. S35-S48
Open Access | Times Cited: 1

EMDL_m6Am: identifying N6,2′-O-dimethyladenosine sites based on stacking ensemble deep learning
Jianhua Jia, Zhangying Wei, Mingwei Sun
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 3

Epigenetic determinants and non-myocardial signaling pathways contributing to heart growth and regeneration
Jihyun Jang, Federica Accornero, Deqiang Li
Pharmacology & Therapeutics (2024) Vol. 257, pp. 108638-108638
Closed Access

Mass Spectrometry Analysis of Nucleic Acid Modifications: From Beginning to Future
Yixuan Xie, Carolina Brás‐Costa, Zongtao Lin, et al.
Mass Spectrometry Reviews (2024)
Closed Access

Page 1

Scroll to top